Longboard Pharmaceuticals Stock Story
| LBPH Stock | USD 19.75 0.52 2.57% |
Under 61% of Longboard Pharmaceuticals' investor base is looking to short. The analysis of the overall investor sentiment regarding Longboard Pharmaceuticals suggests that many traders are alarmed. Longboard Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Longboard Pharmaceuticals. The current market sentiment, together with Longboard Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Longboard Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Longboard Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Longboard daily returns and investor perception about the current price of Longboard Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
Longboard |
Requested story not found. it has been either deleted or moved. View all stories for Longboard Pharmaceuticals.
Longboard Pharmaceuticals Latest Timeline
Longboard Pharmaceuticals is listed for 19.75. About 65.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 2.39. Longboard Pharmaceuticals had not issued any dividends in recent years.Check out Longboard Pharmaceuticals Hype Analysis, Longboard Pharmaceuticals Correlation and Longboard Pharmaceuticals Performance. For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Complementary Tools for Longboard Stock analysis
When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Longboard Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.39) | Return On Assets (0.58) | Return On Equity (1.06) |
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.